Glass 5.6 Max achieved the highest score on the Harvard-Stanford ARISE Medical AI Superintelligence Test (MAST), outperforming other systems in clinical judgment assessment. This test evaluates an AI's ability to adapt its judgment to new patient information.
Key points
• Glass 5.6 Max earned the top SCT-Bench score in the MAST.
• The benchmark uses Script Concordance Testing to assess clinical judgment where experts may disagree.
• MAST evaluates AI performance in updating judgment as new patient information becomes available.
Sources
- Glass Health - Company website for Glass 5.6 Max
Corporate Information - Sanofi Q2 2026 Results
Sanofi has released its financial results for the second quarter of 2026. A detailed press release is available for review.
Key points
• Sanofi's Q2 2026 financial results are now public.
Sources
- Sanofi Press Release - Detailed insights into Q2 2026 financial performance
AI in Biology - Expanding Engineering Capabilities
AI supports drug discovery and biological engineering by enabling new approaches to exploring biological sequence data. Foundation models assist researchers in areas like protein design and genome editing.
Key points
• AI accelerates drug discovery processes.
• Foundation models enable exploration of biological sequence space.
• AI expands engineering possibilities in protein design and genome editing.
Sources
Medical Data - Longitudinal MRI Comparison
Access to longitudinal patient data, such as annual MRI comparisons, provides insights for proactive medical care. This allows for direct observation of changes over time.
Key points
• Comparing annual MRIs offers a direct view of changes over time.
• Longitudinal data is valuable for understanding patient health progression.
• Proactive healthcare benefits from consistent, historical medical imaging.
Genetic Testing - Embryo Analysis with Nucleus
Nucleus provides additional genetic analysis for embryos, complementing traditional chromosomal screening. This helps parents with critical decisions by offering a deeper layer of genetic information.
Key points
• Traditional embryo testing determines if an embryo is chromosomally normal.
• Nucleus adds another layer of genetic analysis to existing embryo testing.
• This analysis assists parents in making informed decisions.
Sources
PKPD Modeling - Script-Based Approaches
This set of scripts addresses pharmacokinetic/pharmacodynamic (PKPD) modeling, distinguishing between model convergence and identifiability. It offers various functions for analysis and simulation.
Key points
• Model convergence does not imply identifiability in PK modeling.
• Scripts cover NCA, compartmental fitting, popPK dataset QC, and regimen simulation.
• Further scripts address exposure-response, bioequivalence, and DDI.
• The tool is opinionated, for example, regarding lambda_z by adjusted R-squared.
Sources
- PKPD Modeling Scripts - Free download for PKPD modeling scripts
